Dechert LLP‘s capital markets practice is driven in large part by the life sciences and permanent capital vehicle clients, including business development companies (BDCs). The firm has worked on a series of notable equity deals including at-the-market offerings. Washington DC-based Harry Pangas heads the US capital markets group and is noted for his work in the BDC sector, as is Boston’s Thomas Friedmann, who co-heads the permanent capital practice. New York’s David Rosenthal co-leads the life sciences team and has extensive experience in capital markets transactions.
Legal 500 redaktioneller Kommentar
- Profil
- Soziale Medien
Anwält*innen
Praxisleitung
Harry Pangas
Weitere Kernanwält*innen
Thomas Friedmann; David Rosenthal